Physiological effects of oxidized exogenous surfactant in vivo: Effects of high tidal volume and surfactant protein A

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 291, Issue 4, 2006, Pages

  Bailey, Timothy C ^a   Maruscak, Adam A ^a   Petersen, Anne ^a   White, Sarah ^a   Lewis, James F ^a   Veldhuizen, Ruud A W ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

Author keywords

Acute lung injury; Mechanical ventilation; Surfactant treatment

Indexed keywords

SURFACTANT; SURFACTANT PROTEIN A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL GAS; ARTICLE; ARTIFICIAL VENTILATION; CONTROLLED STUDY; EXOGENOUS VARIABLE; IN VIVO STUDY; LUNG COMPLIANCE; LUNG FUNCTION; LUNG RECEPTOR; MALE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; RAT; SUPPLEMENTATION; TIDAL VOLUME;

ANIMALS; ARTERIES; BLOOD GAS ANALYSIS; BRONCHOALVEOLAR LAVAGE FLUID; DRUG COMBINATIONS; HUMANS; LUNG; LUNG COMPLIANCE; MALE; OSMOLAR CONCENTRATION; OXIDATION-REDUCTION; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A; PULMONARY SURFACTANTS; RATS; RATS, SPRAGUE-DAWLEY; RESPIRATION, ARTIFICIAL; TIDAL VOLUME;

EID: 33749357389     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00538.2005     Document Type: Article

References (41)

1. Andersson S, Kheiter A, and Merritt TA. Oxidative inactivation of surfactants. Lung 177: 179-189, 1999.
2. Artigas A, Bernard GR, Carlet J, Dreyfuss D, Gattinoni L, Hudson L, Lamy M, Marini JJ, Matthay MA, Pinsky MR, Spragg R, and Suter PM. The American-European Consensus Conference on ARDS. II. Ventilatory, pharmacologic, supportive therapy, study design strategies, and issues related to recovery and remodeling. Am J Respir Crit Care Med 157: 1332-1347, 1998.
3. Bailey TC, Da Silva KA, Lewis JF, Rodriguez-Capote K, Possmayer F, and Veldhuizen RA. Physiological and inflammatory response to instillation of an oxidized surfactant in a rat model of surfactant deficiency. J Appl Physiol 96: 1674-1680, 2004.
4. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, Legall JR, Morris A, Spragg R, and the Consensus Committee. The American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 149: 818-824, 1994.
5. Bligh EG and Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37: 911-917, 1959.
6. Brackenbury AM, Malloy JL, McCaig LA, Yao LJ, Veldhuizen RA, and Lewis JF. Evaluation of alveolar surfactant aggregates in vitro and in vivo. Eur Respir J 19: 41-46, 2002.
7. Brower RG, Matthay MA, Morris A, Schoenfeld D, Thompson BT, and Wheeler A. Ventilation with lower tidal volumes compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 342: 1301-1308, 2000.
8. Cockshutt AM, Weitz J, and Possmayer F. Pulmonary surfactant-associated protein A enhances the surface activity of lipid extract surfactant and reverses inhibition by blood proteins in vitro. Biochemistry 29: 8424-8429, 1990.
9. Crouch E and Wright J. Surfactant proteins A and D and pulmonary host defense. Annu Rev Physiol 63: 521-554, 2001.
10. Dreyfuss D and Saumon G. Ventilator-induced lung injury: lessons from experimental studies. Am J Respir Crit Care Med 157: 294-323, 1998.
11. Dreyfuss D, Soler P, Basset G, and Saumon G. High inflation pressure pulmonary edema. Respective effects of high airway pressure, high tidal volume, and positive end-expiratory pressure. Am Rev Respir Dis 137: 1159-1164, 1988.
12. Duck-Chong CG. A rapid sensitive method for determining phospholipid phosphorus involving digestion with magnesium nitrate. Lipids 14: 492-497, 1979.
13. Enhorning G. Pulsating bubble technique for evaluating pulmonary surfactant. J Appl Physiol 43: 198-203, 1977.
14. Goerke J. Pulmonary surfactant: functions and molecular composition. Biochim Biophys Acta 1408: 79-89, 1998.
15. Gregory TJ, Longmore WJ, Moxley MA, Whitsett JA, Reed CR, Fowler AA, Maunder RJ, Crim C, and Hyers TM. Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J Clin Invest 88: 1976-1981, 1991.
16. Gunther A, Siebert C, Schmidt R, Ziegler S, Grimminger F, Yabut M, Temmesfeld B, Walmrath D, Morr H, and Seeger W. Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema. Am J Respir Crit Care Med 153: 176-184, 1996.
17. Haagsman HP, White RT, Schilling J, Lau K, Benson BJ, Golden J, and Hawgood S. Studies of the structure of lung surfactant protein SP-A. Am J Physiol Lung Cell Mol Physiol 257: L421-L429, 1989.
18. Holm BA, Venkitaraman AR, Enhorning G, and Notter RH. Biophysical inhibition of synthetic lung surfactants. Chem Phys Lipids 52: 243-250, 1990.
19. Jain D, Dodia C, Bates SR, Hawgood S, Poulain FR, and Fisher AB. SP-A is necessary for increased clearance of alveolar DPPC with hyperventilation or secretagogues. Am J Physiol Lung Cell Mol Physiol 284: L759-L765, 2003.
20. Korfhagen TR, Bruno MD, Ross GF, Huelsman KM, Ikegami M, Jobe AH, Wert SE, Stripp BR, Morris RE, Glasser SW, Bachurski CJ, Iwamoto HS, and Whitsett JA. Altered surfactant function and structure in SP-A gene targeted mice. Proc Natl Acad Sci USA 93: 9594-9599, 1996.
21. Korfhagen TR, LeVine AM, and Whitsett JA. Surfactant protein A (SP-A) gene targeted mice. Biochim Biophys Acta 1408: 296-302, 1998.
22. Kuroki Y, Mason RJ, and Voelker DR. Pulmonary surfactant apoprotein A structure and modulation of surfactant secretion by rat alveolar type II cells. J Biol Chem 263: 3388-3394, 1988.
23. Lang JD, McArdle PJ, O'Reilly PJ, and Matalon S. Oxidant-antioxidant balance in acute lung injury. Chest 122: 314S-320S, 2002.
24. LeVine AM, Whitsett JA, Gwozdz JA, Richardson TR, Fisher JH, Burhans MS, and Korfhagen TR. Distinct effects of surfactant protein A or D deficiency during bacterial infection on the lung. J Immunol 165: 3934-3940, 2000.
25. Lewis JF and Veldhuizen R. The role of exogenous surfactant in the treatment of acute lung injury. Annu Rev Physiol 65: 613-642, 2003.
26. Maier RV. Pathogenesis of multiple organ dysfunction syndrome-endotoxin, inflammatory cells, and their mediators: cytokines and reactive oxygen species. Surg Infect 1: 197-205, 2000.
27. McCormack FX. Structure, processing and properties of surfactant protein A. Biochim Biophys Acta 1408: 109-131, 1998.
28. Mehta S and Slutsky AS. Mechanical ventilation in acute respiratory distress syndrome: evolving concepts. Monaldi Arch Chest Dis 53: 647-653, 1998.
29. Putman E, Creuwels LA, Van Golde LM, and Haagsman HP. Surface properties, morphology and protein composition of pulmonary surfactant subtypes. Biochem J 320: 599-605, 1996.
30. Rodriguez-Capote K, Manzanares D, Haines T, and Possmayer F. Reactive oxygen species inactivation of surfactant involves structural and functional alterations to surfactant proteins SP-B and SP-C. Biophys J 90: 2808-2821, 2006.
31. Rodriguez-Capote K, McCormack FX, and Possmayer F. Pulmonary surfactant protein-A (SP-A) restores the surface properties of surfactant after oxidation by a mechanism that requires the Cys6 interchain disulfide bond and the phospholipid binding domain. J Biol Chem 278: 20461-20474, 2003.
32. Schuessler TF and Bates JH. A computer-controlled research ventilator for small animals: design and evaluation. IEEE Trans Biomed Eng 42: 860-866, 1995.
33. Spragg RG. Surfactant therapy in acute respiratory distress syndrome. Biol Neonate 74, Suppl 20, 1998.
34. Spragg RG. Surfactant replacement therapy. Clin Chest Med 21: 531-541, 2000.
35. Strayer DS, Herting E, Sun B, and Robertson B. Antibody to surfactant protein A increases sensitivity of pulmonary surfactant to inactivation by fibrinogen in vivo. Am J Respir Crit Care Med 153: 1116-1122, 1996.
36. Veldhuizen RA, McCaig LA, Akino T, and Lewis JF. Pulmonary surfactant subfractions in patients with the acute respiratory distress syndrome. Am J Respir Crit Care Med 152: 1867-1871, 1995.
37. Veldhuizen RA, Welk B, Harbottle R, Hearn S, Nag K, Petersen N, and Possmayer F. Mechanical ventilation of isolated rat lungs changes the structure and biophysical properties of surfactant. J Appl Physiol 92: 1169-1175, 2002.
38. Veldhuizen RAW, Marcou J, Yao LJ, McCaig L, Ito Y, and Lewis JF. Alveolar surfactant aggregate conversion in ventilated normal and injured rabbits. Am J Physiol Lung Cell Mol Physiol 270: L152-L158, 1996.
39. Verbrugge SJ, Sorm V, and Lachmann B. Mechanisms of acute respiratory distress syndrome: role of surfactant changes and mechanical ventilation. J Physiol Pharmacol 48: 537-557, 1997.
40. Wright JR and Clements JA. Metabolism and turnover of lung surfactant. Am Rev Respir Dis 136: 426-444, 1987.
41. Wright JR, Wager RE, Hawgood S, Dobbs L, and Clements JA. Surfactant apoprotein Mr = 26,000-36,000 enhances uptake of liposomes by type II cells. J Biol Chem 262: 2888-2894, 1987.